Sphingolipid metabolism and complement signaling in cancer progression.

Trends Cancer

Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA. Electronic address:

Published: October 2023

Cancer treatment options are limited due to therapeutic resistance; thus, understanding the tumor microenvironment (TME) is crucial. Sphingolipid metabolism and complement activation products have essential roles in promoting tumor survival. Emerging evidence shows that sphingolipid signaling can regulate intracellular complement activation to induce inflammasome-mediated metastasis, offering a promising strategy for cancer therapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528689PMC
http://dx.doi.org/10.1016/j.trecan.2023.07.001DOI Listing

Publication Analysis

Top Keywords

sphingolipid metabolism
8
metabolism complement
8
complement activation
8
complement signaling
4
signaling cancer
4
cancer progression
4
progression cancer
4
cancer treatment
4
treatment options
4
options limited
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!